Psychedelics have become the new mental health buzzword. With clinical trials supporting psychedelic treatments for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression and anxiety, it’s only a matter of time before big pharmaceutical companies begin to invest heavily, and incorporate psychedelics into their own drug pipelines.
In addition, Institutions such as Johns Hopkins are finding that psychedelics can assist in the treatment of many health and mental issues impacting millions of people around the world. Even the University of California, San Francisco formed a Neuroscape Psychedelics Division to focus on the delivery of “more personalized and precise psychedelic treatments for various mental health conditions,” as noted by the Psychiatry & Behavioral Health Learning Network.
In short, the psychedelics story is only growing stronger by the day.